Clinical trial registry record

Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase 1, phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated October 4, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05827757
Last registry update
October 4, 2023
Status
Unknown
Phase
Phase 1, Phase 2
Sponsor
DNA International Hospital
Enrollment
72
Countries
Vietnam
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1, Phase 2
Study design
NA · SINGLE GROUP · PREVENTION · NONE
Evidence population
Human clinical study registration
Participants
72
Population
ALL · 40 Years to 64 Years
Duration
2020-04-28 to 2025-04-13
Intervention
autologous adipose-derived mesenchymal stem cell transplantation
Comparator
Not reported
Outcomes measured
The safety and toleration of stem cell infusion — Study recruirement day 0; The safety and toleration of stem cell infusion — Day 90; The safety and toleration of stem cell infusion — Study endpoint at day 180; The change of proinflammatory cytokines after stem cell transplantation in patients — Day 0, Day 90 and Day 180; The change of anti-inflammatory cytokines after stem cell transplantation in patients — Day 0, Day 90 and Day 180; The influence of stem cell transplantation on thechange of the ratio of pro-inflammatory to anti-inflammatory cytokines…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1, Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Stem cells · 100%Title contains controlled term: stem cell. Abstract contains controlled term: stem cell. Source terminology contains: stem cell. Title supplies longevity context: ageing. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

stem cells
Open primary sourceExport JSON